LivaNova PLC (NAS:LIVN)
$ 52.52 0.21 (0.4%) Market Cap: 2.85 Bil Enterprise Value: 3.20 Bil PE Ratio: 0 PB Ratio: 2.29 GF Score: 70/100

LivaNova PLC at Goldman Sachs Global Healthcare Conference Transcript

Jun 15, 2022 / 05:00PM GMT
Release Date Price: $59.94 (-3.97%)
Amit Hazan
Goldman Sachs Group, Inc., Research Division - Equity Analyst

All right. Good morning, everyone. Hope you can hear me okay. I'm Amit Hazan. I'm a medical technology analyst here at Goldman Sachs, and I'm getting ready to kick off Day 3 for the med-tech conversations at least. And we're really excited to have back with us at this conference, LivaNova, and we've got the whole crew here with us. First, before I introduce them, Phil Coover, one of my partners on the med-tech team is here too to ask questions.

And so we've got CEO, Damien McDonald; CFO Alex Shvartsburg; and Senior Vice President and Corporate Development Matt Dodds. I bet you can recognize who is who here, without me asking. So guys thank you so much for being here today, and we're excited to get the updates from you. As you might imagine, at this conference so far this week, we've always -- we've been starting the conversations with the macro stuff.

Questions & Answers

Amit Hazan
Goldman Sachs Group, Inc., Research Division - Equity Analyst

That's still top of mind

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot